Recruiting

Quill vs. Monocryl

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04906174

Conditions

Liver and Intrahepatic Bile Duct Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Electronic Health Record Review

Study Details

Brief summary:

This study investigates the effect of materials used in subcuticular suture on patients' outcomes after surgery. The prevention of surgical site wound infection is important to decrease the length of hospital stay and the post-operative risk of incisional hernia, especially in patients undergoing open hepatectomy (surgical removal of the liver). The purpose of this study is to compare the impact of the use of Quill versus Monocryl for subcuticular suture on patients' outcomes after surgery.

Conditions

Liver and Intrahepatic Bile Duct Neoplasm

Study ID

NCT04906174

Start date

Apr 10, 2021

Status verified date

Apr, 2023

Completion date

Dec 31, 2023

Anticipated

Primary completion date

Dec 31, 2023

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients >= 18 years of age undergoing liver resection at MD Anderson Cancer Center from June 1, 2020 through January 31, 2021

Exclusion Criteria:

  • Patients who have a history of previous abdominal surgery will be excluded
  • Pregnant women will not be included in this chart review

Study Design

Enrollment

40 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (medical record review)

Patients' medical records are reviewed retrospectively.

Interventions

Electronic Health Record Review

Medical records are reviewed

Primary outcome measure

  • Incidence of complications after liver resection [ Time Frame: 1 year ]

Central Contacts and Locations

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Principal Investigator:

Jean-Nicolas Vauthey

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Apr 12, 2023

Last verified

Apr, 2023

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2023-04-12.